Market Summary
USD484.72+10.92
Market Closed2.30%
HUM Alerts
HUM Stock Price
HUM RSI Chart
HUM Valuation
HUM Price/Sales (Trailing)
HUM Profitability
HUM Fundamentals
HUM Revenue
HUM Earnings
Price Action
52 Week Range
423.29571.30
(Low)(High)
Last 7 days
1.0%
Last 30 days
-3.4%
Last 90 days
4.7%
Trailing 12 Months
-5.4%
HUM Financial Health
HUM Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for HUM
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-08-01 | Diamond Susan M | sold (taxes) | -66,429 | 458 | -145 | chief financial officer |
2023-08-01 | Felter John-Paul W. | sold (taxes) | -29,778 | 458 | -65.00 | svp, chief accting off & cont. |
2023-08-01 | Felter John-Paul W. | acquired | - | - | 210 | svp, chief accting off & cont. |
2023-08-01 | Diamond Susan M | acquired | - | - | 311 | chief financial officer |
2023-05-05 | Diamond Susan M | sold | - | - | -700 | chief financial officer |
2023-05-04 | Diamond Susan M | acquired | 1,220,740 | 362 | 3,369 | chief financial officer |
2023-05-04 | Diamond Susan M | gifted | - | - | -100 | chief financial officer |
2023-05-04 | Diamond Susan M | sold | -2,187,230 | 526 | -4,156 | chief financial officer |
2023-03-01 | Feinberg David T | acquired | - | - | 441 | - |
2023-02-28 | JONES DAVID A JR/KY | gifted | - | - | -10,000 | - |
Which funds bought or sold HUM recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-09-12 | Farther Finance Advisors, LLC | reduced | -28.66 | -579,138 | 1,109,780 | 0.24% |
2023-09-05 | Delos Wealth Advisors, LLC | unchanged | - | -38.00 | 448 | -% |
2023-09-05 | Covenant Partners, LLC | unchanged | - | -21,465 | 250,393 | 0.09% |
2023-09-01 | Portside Wealth Group, LLC | new | - | 785,628 | 785,628 | 0.15% |
2023-08-28 | Banco BTG Pactual S.A. | new | - | 869,220 | 869,220 | 0.17% |
2023-08-24 | Alberta Investment Management Corp | added | 66.28 | 3,165,380 | 9,121,000 | 0.09% |
2023-08-23 | Stonebridge Capital Advisors LLC | sold off | -100 | -3,398 | - | -% |
2023-08-23 | WOLVERINE TRADING, LLC | new | - | 937,876 | 937,876 | -% |
2023-08-22 | Segment Wealth Management, LLC | unchanged | - | -33,654 | 392,580 | 0.04% |
2023-08-22 | Old North State Trust, LLC | sold off | -100 | -75,000 | - | -% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
HUM Alerts
Schedule 13G FIlings of Humana
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 14, 2023 | price t rowe associates inc /md/ | 6.0% | 7,623,150 | SC 13G/A | |
| Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 8.97% | 11,357,974 | SC 13G/A | |
| Feb 06, 2023 | wellington management group llp | 6.01% | 7,611,181 | SC 13G | |
| Jan 25, 2023 | blackrock inc. | 9.2% | 11,628,073 | SC 13G/A | |
| Jun 09, 2022 | blackrock inc. | 10.1% | 12,733,508 | SC 13G/A | |
| Feb 14, 2022 | price t rowe associates inc /md/ | 8.1% | 10,508,002 | SC 13G/A | |
| Feb 10, 2022 | vanguard group inc | 7.79% | 10,008,322 | SC 13G/A | |
| Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A | |
| Feb 01, 2022 | blackrock inc. | 8.8% | 11,254,355 | SC 13G/A |
Recent SEC filings of Humana
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Sep 19, 2023 | 4 | Insider Trading | |
| Sep 06, 2023 | 8-K | Current Report | |
| Aug 21, 2023 | 8-K | Current Report | |
| Aug 03, 2023 | 4 | Insider Trading | |
| Aug 03, 2023 | 4 | Insider Trading | |
| Aug 02, 2023 | 8-K | Current Report | |
| Aug 02, 2023 | 10-Q | Quarterly Report | |
| Jul 05, 2023 | 4 | Insider Trading | |
| Jul 05, 2023 | 4 | Insider Trading | |
| Jul 05, 2023 | 4 | Insider Trading |
Peers (Alternatives to Humana)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
UNH | 445.6B | 348.5B | -3.57% | -7.58% | 21.11 | 1.28 | 13.69% | 15.63% |
CI | 91.1B | 186.1B | 3.13% | -0.86% | 13.64 | 1.92 | 3.72% | 22.38% |
HUM | 65.7B | 98.7B | -3.38% | -5.44% | 23.41 | 0.71 | 10.45% | 7.48% |
CNC | 37.0B | 147.9B | 6.51% | -19.96% | 13.66 | 0.25 | 7.12% | 45.86% |
| MID-CAP | ||||||||
HQY | 6.1B | 937.9M | 5.74% | -1.29% | 473.62 | 6.48 | 17.97% | 120.64% |
LHCG | 5.2B | 2.3B | 3.17% | 35.63% | 86.23 | 2.28 | 2.85% | -58.05% |
CRVL | 3.4B | 732.5M | -11.21% | 29.57% | 48.43 | 4.59 | 9.34% | 4.86% |
AMN | 3.3B | 4.4B | -1.92% | -18.46% | 10.4 | 0.76 | -16.06% | -30.43% |
PDCO | 2.8B | 6.5B | -15.03% | 11.13% | 13.03 | 0.43 | 1.83% | 10.70% |
| SMALL-CAP | ||||||||
RDNT | 1.9B | 1.5B | -5.48% | 41.28% | -147.37 | 1.24 | 12.20% | -155.34% |
ADUS | 1.4B | 999.1M | -8.19% | -9.37% | 25.2 | 1.36 | 10.42% | 21.37% |
BKD | 779.3M | 3.0B | -0.48% | -21.89% | -7.56 | 0.26 | 11.66% | -12.20% |
Humana News
Returns for HUM
Cumulative Returns on HUM
18.1%
10-Year Cumulative Returns
16.0%
7-Year Cumulative Returns
7.6%
5-Year Cumulative Returns
6.0%
3-Year Cumulative Returns
Risks for HUM
What is the probability of a big loss on HUM?
63.1%
Probability that Humana stock will be more than 20% underwater in next one year
19.2%
Probability that Humana stock will be more than 30% underwater in next one year.
0%
Probability that Humana stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does HUM drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Humana was unfortunately bought at previous high price.
Drawdowns
Financials for Humana
Income Statement (Last 12 Months)(In Millions)
| Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Revenue | 3.2% | 98,727 | 95,642 | 92,870 | 91,485 | 89,383 | 86,366 | 83,064 | 81,072 | 80,450 | 78,888 | 77,155 | 74,388 | 70,554 | 67,716 | 64,888 | 62,761 | 60,726 | 58,740 | 56,912 | 55,933 | 55,009 |
| S&GA Expenses | -0.5% | 12,702 | 12,764 | 12,671 | 12,515 | 12,057 | 11,000 | 10,121 | 9,794 | 9,704 | 9,942 | 10,052 | 9,113 | 8,489 | 7,838 | 7,381 | 7,367 | 7,378 | 7,436 | 7,525 | 7,283 | 7,071 |
| EBITDA | -100.0% | - | 5,154 | 4,718 | 4,690 | 4,989 | 4,590 | 4,385 | 3,944 | 4,048 | 5,797 | 5,453 | 6,484 | 5,570 | 4,184 | 4,210 | 4,054 | 4,036 | 2,794 | 2,734 | 2,798 | 2,683 |
| EBITDA Margin | -100.0% | - | 0.05* | 0.05* | 0.05* | 0.06* | 0.05* | 0.05* | 0.05* | 0.05* | 0.07* | 0.07* | 0.09* | 0.08* | 0.06* | 0.06* | 0.06* | 0.07* | 0.05* | 0.05* | 0.05* | 0.05* |
| Interest Expenses | 4.5% | 443 | 424 | 401 | 384 | 370 | 348 | 326 | 307 | 294 | 291 | 283 | 269 | 256 | 240 | 242 | 243 | 234 | 227 | 218 | 235 | 241 |
| Earnings Before Taxes | 3.5% | 4,102 | 3,962 | 3,568 | 3,579 | 3,918 | 3,534 | 3,354 | 2,956 | 3,075 | 4,923 | 4,600 | 5,651 | 4,784 | 3,427 | 3,456 | 3,299 | 3,312 | 2,102 | 2,063 | 2,117 | 2,015 |
| EBT Margin | -100.0% | - | 0.04* | 0.04* | 0.04* | 0.05* | 0.04* | 0.04* | 0.04* | 0.04* | 0.06* | 0.06* | 0.08* | 0.07* | 0.05* | 0.05* | 0.05* | 0.05* | 0.04* | 0.04* | 0.04* | 0.04* |
| Net Income | 8.4% | 3,378 | 3,115 | 2,806 | 2,807 | 3,143 | 3,035 | 2,933 | 2,673 | 2,482 | 3,722 | 3,367 | 4,153 | 3,502 | 2,614 | 2,707 | 2,550 | 2,505 | 1,758 | 1,683 | 1,512 | 1,367 |
| Net Income Margin | -100.0% | - | 0.03* | 0.03* | 0.03* | 0.04* | 0.04* | 0.04* | 0.03* | 0.03* | 0.05* | 0.04* | 0.06* | 0.05* | 0.04* | 0.04* | 0.04* | 0.04* | 0.03* | 0.03* | 0.03* | 0.02* |
| Free Cashflow | -100.0% | - | 9,924 | 3,467 | 8,385 | 2,729 | 2,080 | 946 | 1,400 | 456 | 3,266 | 4,675 | 4,970 | 5,637 | 4,073 | 4,548 | 3,757 | 306 | -1,234 | 1,561 | -989 | 2,950 |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Assets | 3.1% | 56,455 | 54,776 | 43,055 | 50,765 | 46,820 | 46,308 | 44,358 | 45,320 | 38,070 | 37,415 | 34,969 | 38,477 | 38,455 | 34,633 | 29,074 | 29,180 | 28,913 | 28,349 | 25,413 | 27,490 | 34,270 |
| Current Assets | 3.3% | 38,759 | 37,532 | 26,183 | 33,711 | 27,217 | 26,840 | 24,893 | 25,815 | 25,790 | 25,526 | 23,641 | 27,031 | 27,868 | 24,551 | 19,888 | 20,324 | 20,160 | 19,673 | 16,948 | 19,077 | 26,864 |
| Cash Equivalents | 18.0% | 16,214 | 13,735 | 5,061 | 13,558 | 5,220 | 4,864 | 3,394 | 4,304 | 3,378 | 3,877 | 4,673 | 7,985 | 7,163 | 6,054 | 4,054 | 5,527 | 4,778 | 3,877 | 2,343 | 4,142 | 8,831 |
| Net PPE | 2.3% | 3,309 | 3,234 | 3,221 | 3,218 | 3,121 | 3,189 | 3,073 | 2,898 | 2,690 | 2,507 | 2,371 | 2,228 | 2,118 | 2,023 | 1,955 | 1,864 | 1,796 | 1,754 | 1,735 | 1,685 | 1,626 |
| Goodwill | 2.3% | 9,539 | 9,320 | 9,142 | 9,096 | 8,911 | 11,139 | 11,092 | 10,806 | 4,914 | 4,602 | 4,447 | 4,443 | 4,443 | 4,443 | 3,928 | 3,922 | 3,922 | 3,897 | 3,897 | 3,895 | 3,895 |
| Liabilities | 3.7% | 39,564 | 38,142 | 27,685 | 34,448 | 31,310 | 30,966 | 28,255 | 29,038 | 23,227 | 23,225 | 21,241 | 22,709 | 24,039 | 22,278 | 17,037 | 17,579 | 17,041 | 17,508 | 15,252 | 16,897 | 24,059 |
| Current Liabilities | 5.0% | 28,279 | 26,942 | 17,178 | 25,051 | 17,839 | 17,532 | 15,331 | 15,027 | 15,051 | 15,300 | 13,394 | 14,905 | 16,455 | 14,830 | 10,929 | 11,106 | 11,539 | 11,927 | 10,077 | 11,324 | 18,768 |
| Short Term Borrowings | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1,694 | 398 | 398 |
| LT Debt, Non Current | -0.2% | 9,722 | 9,743 | 9,034 | 7,798 | 11,290 | 11,285 | 10,541 | 11,466 | 6,063 | 6,062 | 6,060 | 6,059 | 6,058 | 6,057 | 4,967 | 5,365 | 4,377 | 4,376 | 4,375 | 4,774 | 4,773 |
| Shareholder's Equity | 1.2% | 16,834 | 16,634 | 15,311 | 16,317 | 15,510 | 15,342 | 16,103 | 16,282 | 14,843 | 14,190 | 13,728 | 15,768 | 14,416 | 12,355 | 12,037 | 11,601 | 11,872 | 10,841 | 10,161 | 10,593 | 10,211 |
| Retained Earnings | 3.2% | 27,468 | 26,619 | 25,492 | 25,606 | 24,511 | 23,915 | 23,086 | 23,191 | 21,751 | 21,252 | 20,517 | 20,872 | 19,616 | 17,871 | 17,483 | 17,045 | 16,429 | 15,563 | 15,072 | 14,786 | 14,211 |
| Additional Paid-In Capital | 1.6% | 3,313 | 3,262 | 3,246 | 3,234 | 3,153 | 3,103 | 3,082 | 3,064 | 3,018 | 2,712 | 2,705 | 2,940 | 2,898 | 2,857 | 2,820 | 2,608 | 2,763 | 2,722 | 2,535 | 2,707 | 2,672 |
| Minority Interest | 0% | 57.00 | 57.00 | 59.00 | 63.00 | 20.00 | 23.00 | 23.00 | 22.00 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cashflow (Last 12 Months)(In Millions)
| Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Cashflow From Operations | 20.2% | 13,189 | 10,972 | 4,587 | 9,618 | 4,000 | 3,401 | 2,262 | 2,641 | 1,621 | 4,328 | 5,639 | 5,868 | 6,495 | 4,862 | 5,284 | 4,439 | 942 | -617 | 2,173 | -405 | 3,513 |
| Share Based Compensation | 0.5% | 212 | 211 | 216 | 221 | 189 | 184 | 180 | 184 | 183 | 184 | 181 | 173 | 169 | 166 | 163 | 151 | 144 | 135 | 137 | 146 | 143 |
| Cashflow From Investing | 17.5% | -1,361 | -1,650 | -1,006 | -96.00 | -6,023 | -5,716 | -6,556 | -6,509 | -2,406 | -3,343 | -3,065 | -3,811 | -4,229 | -2,633 | -1,278 | -924 | -2,711 | -2,537 | -3,087 | -3,805 | -2,150 |
| Cashflow From Financing | -84.9% | -834 | -451 | -1,914 | -268 | 3,865 | 3,302 | 3,015 | 187 | -3,000 | -3,162 | -1,955 | 401 | 119 | -52.00 | -2,295 | -2,130 | -2,284 | -1,824 | -785 | -1,513 | -671 |
| Dividend Payments | 2.7% | 412 | 401 | 392 | 382 | 372 | 362 | 354 | 347 | 340 | 333 | 323 | 314 | 305 | 296 | 291 | 286 | 281 | 276 | 265 | 253 | 242 |
| Buy Backs | 45.0% | 1,691 | 1,166 | 2,096 | 1,075 | 1,074 | 1,073 | 79.00 | 1,826 | 1,828 | 1,833 | 1,820 | 90.00 | 1,085 | 1,077 | 1,070 | 1,806 | 1,007 | 1,049 | 1,090 | 1,840 | 1,880 |
HUM Income Statement
2023-06-30CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
| Income Statement [Abstract] | ||||
| Revenue from Contract with Customer, Product and Service [Extensible Enumeration] | Health Care [Member] | Health Care [Member] | Health Care [Member] | Health Care [Member] |
| Revenues: | ||||
| Premiums | $ 25,495 | $ 22,266 | $ 51,045 | $ 44,969 |
| Services | 978 | 1,349 | 1,977 | 2,613 |
| Investment income | 274 | 47 | 467 | 50 |
| Total revenues | 26,747 | 23,662 | 53,489 | 47,632 |
| Operating expenses: | ||||
| Benefits | 22,009 | 19,099 | 43,867 | 38,724 |
| Operating costs | 3,111 | 3,173 | 6,090 | 6,059 |
| Depreciation and amortization | 191 | 175 | 377 | 345 |
| Total operating expenses | 25,311 | 22,447 | 50,334 | 45,128 |
| Income (loss) from operations | 1,436 | 1,215 | 3,155 | 2,504 |
| Interest expense | 120 | 101 | 233 | 191 |
| Other expense (income), net | 54 | (8) | 46 | (29) |
| Income before income taxes and equity in net losses | 1,262 | 1,122 | 2,876 | 2,342 |
| Provision for income taxes | 296 | 427 | 655 | 713 |
| Equity in net (losses) earnings | (10) | 2 | (27) | (2) |
| Net income | 956 | 697 | 2,194 | 1,627 |
| Net loss (income) attributable to noncontrolling interests | 3 | (1) | 4 | (1) |
| Net income attributable to Humana | $ 959 | $ 696 | $ 2,198 | $ 1,626 |
| Basic earnings per common share (in dollars per share) | $ 7.70 | $ 5.50 | $ 17.62 | $ 12.83 |
| Diluted earnings per common share (in dollars per share) | $ 7.66 | $ 5.48 | $ 17.54 | $ 12.77 |
HUM Balance Sheet
2023-06-30CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions | Jun. 30, 2023 | Dec. 31, 2022 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 16,214 | $ 5,061 |
| Investment securities | 15,251 | 13,881 |
| Receivables, net of allowances of $72 in 2023 and $70 in 2022 | 1,429 | 1,674 |
| Other current assets | 5,865 | 5,567 |
| Total current assets | 38,759 | 26,183 |
| Property and equipment, net | 3,309 | 3,221 |
| Long-term investment securities | 389 | 380 |
| Equity method investments | 733 | 749 |
| Goodwill | 9,539 | 9,142 |
| Other long-term assets | 3,726 | 3,380 |
| Total assets | 56,455 | 43,055 |
| Current liabilities: | ||
| Benefits payable | 10,304 | 9,264 |
| Trade accounts payable and accrued expenses | 8,118 | 5,238 |
| Book overdraft | 457 | 298 |
| Unearned revenues | 7,378 | 286 |
| Short-term debt | 2,022 | 2,092 |
| Total current liabilities | 28,279 | 17,178 |
| Long-term debt | 9,722 | 9,034 |
| Other long-term liabilities | 1,563 | 1,473 |
| Total liabilities | 39,564 | 27,685 |
| Stockholders’ equity: | ||
| Preferred stock, $1 par; 10,000,000 shares authorized; none issued | 0 | 0 |
| Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,690,082 shares issued at June 30, 2023 and 198,666,598 shares issued at December 31, 2022 | 33 | 33 |
| Capital in excess of par value | 3,313 | 3,246 |
| Retained earnings | 27,468 | 25,492 |
| Accumulated other comprehensive loss | (1,226) | (1,304) |
| Treasury stock, at cost, 74,783,332 shares at June 30, 2023 and 73,691,955 shares at December 31, 2022 | (12,754) | (12,156) |
| Total stockholders' equity | 16,834 | 15,311 |
| Noncontrolling interests | 57 | 59 |
| Total equity | 16,891 | 15,370 |
| Total liabilities and equity | $ 56,455 | $ 43,055 |
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.